Tarsus Pharmaceuticals, Inc. TARS Enterprise value

Enterprise value at other companies

AbbVieABBV

$460.96B+24.7%

Bausch + LombBLCO

$10.6B+18.6%

Ocular TherapeutixOCUL

$1.26B+40.8%

HRO

HarrowHROW

$1.53B+13.8%

EyePoint, Inc.EYPT

$1.11B+90.1%

TTR

Turn Therapeutics Inc.TTRX

$89.01M—

FAQ

What is Tarsus Pharmaceuticals, Inc.'s enterprise value?

Tarsus Pharmaceuticals, Inc. (TARS) reported enterprise value of $2.59B in Q2 2026.

How has Tarsus Pharmaceuticals, Inc.'s enterprise value changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s enterprise value increased by 51.2% year-over-year, from $1.71B to $2.59B.

What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s enterprise value has grown at a 38.0% compound annual growth rate (CAGR), from $673.17M to $3.37B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.